Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today provided additional context regarding its previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback